Advertisement

Phenomenology of Atypical Anxiety Disorders in Parkinson's Disease: A Systematic Review

Published:February 15, 2022DOI:https://doi.org/10.1016/j.jagp.2022.02.004

      Highlights

      • What is the primary question addressed by this study?
        A systematic review was conducted to better define and describe the clinical presentation of atypical anxiety in Parkinson's disease in order to help improve recognition, advance therapeutic development and ultimately optimize routine PD care.
      • What is the main finding of this study?
        Across the 60 studies meeting inclusion criteria, estimates of atypical anxiety ranged from 15%–51%. We identified a diverse array of anxiety symptoms related to motor and non-motor symptoms of PD, to complications of PD medications (such as “on” and “off” fluctuations), and, to a lesser extent, to cognitive symptoms.
      • What is the meaning of the finding?
        Atypical anxiety is highly prevalent, clinically relevant, heterogeneous in nature, and a key target for intervention in multidisciplinary PD care.

      Abstract

      Objective

      Anxiety is a prominent concern in Parkinson's disease (PD) that negatively impacts quality of life, increases functional disability, and complicates clinical management. Atypical presentations of anxiety are under-recognized and inadequately treated in patients with PD, compromising global PD care.

      Methods

      This systematic review focuses on the prevalence, symptomology and clinical correlates of atypical presentations of PD-related anxiety following PRISMA guidelines.

      Results

      Of the 60 studies meeting inclusion criteria, 14 focused on 'Anxiety Not Otherwise Specified (NOS)’ or equivalent, 31 reported on fluctuating anxiety symptoms, and 22 reported on 'Fear of Falling (FOF)'. Anxiety NOS accounted for a weighted mean prevalence of 14.9%, fluctuating anxiety for 34.19%, and FOF for 51.5%. These latter two exceeded the average reported overall prevalence rate of 31% for anxiety disorders in PD. We identified a diverse array of anxiety symptoms related to motor and non-motor symptoms of PD, to complications of PD medication (such as “on” and “off” fluctuations, or both), and, to a lesser extent, to cognitive symptoms.

      Conclusion

      Atypical anxiety is common, clinically relevant, and heterogeneous in nature. A better understanding of the phenomenology, clinical course, and pathophysiology of varied forms of atypical anxiety in PD is needed to improve recognition, advance therapeutic development and ultimately optimize quality of life in PD.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Geriatric Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Broen MPG
        • Narayen NE
        • Kuijf ML
        • et al.
        Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis.
        Mov Disord. 2016; 31: 1125-1133
        • Dissanayaka NNNW
        • White E
        • O'Sullivan JD
        • et al.
        The clinical spectrum of anxiety in Parkinson's disease.
        Mov Disord. 2014; 29: 967-975
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
        5th ed. American Psychiatric Association, Washington, DC Arlington, VA2013
        • Moher D
        • Liberati A
        • Tetzlaff J
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        Bmj-Brit Med J. 2009; 339: b2535
        • Whiting P
        • Rutjes AW
        • Reitsma JB
        • et al.
        The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.
        BMC Med Res Methodol. 2003; 3: 25
        • Thordardottir B
        • Nilsson M
        • Iwarsson S
        • et al.
        "You plan, but you never know'' - participation among people with different levels of severity of Parkinson's disease.
        Disabil Rehabil. 2014; 36: 2216-2224
        • Dissanayaka NNW
        • O'Sullivan JD
        • Pachana NA
        • et al.
        Disease-specific anxiety symptomatology in Parkinson's disease.
        Int Psychogeriatr. 2016; 28: 1153-1163
        • Pontone GM
        • Williams JR
        • Anderson KE
        • et al.
        Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease.
        Mov Disord. 2009; 24: 1333-1338
        • Chen Y-K
        • Lu J-Y
        • Chan DML
        • et al.
        Anxiety disorders in Chinese patients with Parkinson's disease.
        Int J Psychiatry Med. 2010; 40: 97-107
        • Ehgoetz Martens KA
        • Ellard CG
        • Almeida QJ
        Evaluating the link between dopaminergic treatment, gait impairment, and anxiety in Parkinson's Disease.
        Movement Disorders Clinical Practice. 2016; 3: 389-394
        • Pontone GM
        • Williams JR
        • Anderson KE
        • et al.
        Anxiety and self-perceived health status in Parkinson's disease.
        Parkinsonism Relat Disord. 2011; 17: 249-254
        • Dissanayaka NNW
        • White E
        • O'Sullivan JD
        • et al.
        Characteristics and treatment of anxiety disorders in Parkinson's Disease.
        Movement Disorders Clinical Practice. 2015; 2: 155-162
        • Pontone GM
        • Palanci J
        • Bienvenu OJ
        • et al.
        Familial aggregation of panic disturbances in Parkinson's Disease.
        J Neuropsychiatry Clin Neurosci. 2011; 23: 417-424
        • Mehdizadeh M
        • Lajevardi L
        • Habibi SAH
        • et al.
        The association between fear of falling and quality of life for balance impairments based on hip and ankle strategies in the drug On- and Off-phase of patients with idiopathic Parkinson' disease.
        Med J Islam Repub Iran. 2016; 30: 453
        • Mehdizadeh M
        • Martinez-Martin P
        • Habibi SA
        • et al.
        The association of balance, fear of falling, and daily activities with drug phases and severity of disease in patients with Parkinson.
        Basic Clin Neurosci. 2019; 10: 355-362
        • Nilsson MH
        • Hariz GM
        • Iwarsson S
        • et al.
        Walking ability is a major contributor to fear of falling in people with Parkinson's disease: implications for rehabilitation.
        Parkinsons Dis. 2012; 2012713236
        • Leentjens AF
        • Dujardin K
        • Marsh L
        • et al.
        Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study.
        Parkinsonism Relat Disord. 2012; 18: 1084-1088
        • Vazquez A
        • Jimenezjimenez FJ
        • Garciaruiz P
        • et al.
        Panic attacks in Parkinsons-disease - a long-term complication of levodopa therapy.
        Acta Neurol Scand. 1993; 87: 14-18
        • Rizos A
        • Martinez-Martin P
        • Odin P
        • et al.
        Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study.
        Parkinsonism Relat Disord. 2014; 20: 1231-1235
        • Siemers ER
        • Shekhar A
        • Quaid K
        • et al.
        Anxiety and motor performance in Parkinson's disease.
        Mov Disord. 1993; 8: 501-506
        • Richard IH
        • Frank S
        • McDermott MP
        • et al.
        The ups and downs of parkinson disease: a prospective study of mood and anxiety fluctuations.
        Cogn Behav Neurol. 2004; 17: 201-207
        • Richard IH
        • Justus AW
        • Kurlan R
        Relationship between mood and motor fluctuations in Parkinson's disease.
        J Neuropsychiatry Clin Neurosci. 2001; 13: 35-41
        • Nissenbaum H
        • Quinn NP
        • Brown RG
        • et al.
        Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
        Psychol Med. 1987; 17: 899-904
        • Henderson R
        • Kurlan R
        • Kersun JM
        • et al.
        Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.
        J Neuropsychiatry Clin Neurosci. 1992; 4: 257-264
        • Storch A
        • Schneider CB
        • Wolz M
        • et al.
        Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications.
        Neurology. 2013; 80: 800-809
        • Ossig C
        • Sippel D
        • Fauser M
        • et al.
        Assessment of nonmotor fluctuations using a diary in advanced Parkinson's disease.
        J Parkinsons Dis. 2016; 6: 597-607
        • Witjas T
        • Kaphan E
        • Azulay JP
        • et al.
        Nonmotor fluctuations in Parkinson's disease - Frequent and disabling.
        Neurology. 2002; 59: 408-413
        • Racette BA
        • Hartlein JM
        • Hershey T
        • et al.
        Clinical features and comorbidity of mood fluctuations in Parkinson's disease.
        J Neuropsychiatry Clin Neurosci. 2002; 14: 438-442
        • Menza MA
        • Sage J
        • Marshall E
        • et al.
        Mood changes and 'on-off' phenomena in Parkinson's disease.
        Mov Disord. 1990; 5: 148-151
        • Kulisevsky J
        • Pascual-Sedano B
        • Barbanoj M
        • et al.
        Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: a double-blind study.
        Mov Disord. 2007; 22: 62-67
        • Maricle RA
        • Nutt JG
        • Valentine RJ
        • et al.
        Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.
        Neurology. 1995; 45: 1757-1760
        • Starkstein SE
        • Dragovic M
        • Dujardin K
        • et al.
        Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach.
        Am J Geriatr Psychiatry. 2014; 22: 1410-1417
        • Brown RG
        • Landau S
        • Hindle JV
        • et al.
        Depression and anxiety related subtypes in Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 2011; 82: 803-809
        • Broen MPG
        • Leentjens AFG
        • Hinkle JT
        • et al.
        Clinical markers of anxiety subtypes in Parkinson disease.
        J Geriatr Psychiatry Neurol. 2018; 31: 55-62
        • Fernie BA
        • Spada MM
        • Brown RG
        Motor Fluctuations and Psychological Distress in Parkinson's Disease.
        Health Psychol. 2019; 38: 518-526
        • Thomas AA
        • Rogers JM
        • Amick MM
        • et al.
        Falls and the falls efficacy scale in Parkinson's disease.
        J Neurol. 2010; 257: 1124-1128
        • Franzen E
        • Conradsson D
        • Hagstromer M
        • et al.
        Depressive symptoms associated with concerns about falling in Parkinson's disease.
        Brain Behav. 2016; 6: e00524
        • Bryant MS
        • Rintala DH
        • Hou J-G
        • et al.
        Influence of fear of falling on gait and balance in Parkinson's disease.
        Disabil Rehabil. 2014; 36: 744-748
        • Adkin AL
        • Frank JS
        Jog MS. Fear of falling and postural control in Parkinson's disease.
        Mov Disord. 2003; 18: 496-502
        • Kwon KY
        • Park S
        • Lee HM
        • et al.
        Backward gait is associated with motor symptoms and fear of falling in patients with de novo Parkinson's disease.
        J Clin Neurol. 2019; 15: 473-479
        • Griffin HJ
        • Greenlaw R
        • Limousin P
        • et al.
        The effect of real and virtual visual cues on walking in Parkinson's disease.
        J Neurol. 2011; 258: 991-1000
        • O'Connell E
        • Guidon M
        Fear of falling and dual-task performance in people with Parkinson's disease.
        Eur J Physiother. 2016; 18: 167-172
        • Lindholm B
        • Hagell P
        • Hansson O
        • et al.
        Factors associated with fear of falling in people with Parkinson's disease.
        BMC Neurol. 2014; 14: 19
        • Hadoush H
        • Al-Jarrah M
        • Khalil H
        • et al.
        Bilateral anodal transcranial direct current stimulation effect on balance and fearing of fall in patient with Parkinson's disease.
        Neuro Rehabilitation. 2018; 42: 63-68
        • Mak MKY
        • Pang MYC
        Fear of falling is independently associated with recurrent falls in patients with Parkinson's disease: a 1-year prospective study.
        J Neurol. 2009; 256: 1689-1695
        • Rahman S
        • Griffin HJ
        • Quinn NP
        • et al.
        On the nature of fear of falling in Parkinson's disease.
        Behav Neurol. 2011; 24: 219-228
        • Bryant MS
        • Rintala DH
        • Hou JG
        • et al.
        Relationship of falls and fear of falling to activity limitations and physical inactivity in Parkinson's disease.
        J Aging Phys Act. 2015; 23: 187-193
        • Kader M
        • Iwarsson S
        • Odin P
        • et al.
        Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson's disease.
        BMC Neurol. 2016; 16: 84
        • Grimbergen YA
        • Schrag A
        • Mazibrada G
        • et al.
        Impact of falls and fear of falling on health-related quality of life in patients with Parkinson's disease.
        J Parkinsons Dis. 2013; 3: 409-413
        • Dobkin RD
        • Rubino JT
        • Friedman J
        • et al.
        Barriers to mental health care utilization in Parkinson's disease.
        J Geriatr Psychiatry Neurol. 2013; 26: 105-116
        • van der Velden RMJ
        • Broen MPG
        • Kuijf ML
        • et al.
        Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: a systematic review.
        Mov Disord. 2018; 33: 1521-1527
        • Mulders AEP
        • van der Velden RMJ
        • Drukker M
        • et al.
        Usability of the experience sampling method in Parkinson's disease on a group and individual level.
        Mov Disord. 2020; 35: 1145-1152
        • Terroba-Chambi C
        • Bruno V
        • Millar-Vernetti P
        • et al.
        Design and validation of a new instrument to assess fear of falling in Parkinson's disease.
        Mov Disord. 2019; 34: 1496-1504
        • Mehdizadeh M
        • Martinez-Martin P
        • Habibi SA
        • et al.
        Reliability and Validity of Fall Efficacy Scale-International in People with Parkinson's Disease during On- and Off-Drug Phases.
        Parkinsons Dis. 2019; 2019: 6505232
        • Nilsson MH
        • Rehncrona S
        • Jarnlo GB
        Fear of falling and falls in people with Parkinson's disease treated with deep brain stimulation in the subthalamic nuclei.
        Acta Neurol Scand. 2011; 123: 424-429
        • Friedman SM
        • Munoz B
        • West SK
        • et al.
        Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention.
        J Am Geriatr Soc. 2002; 50: 1329-1335
        • Yardley L
        • Beyer N
        • Hauer K
        • et al.
        Development and initial validation of the Falls Efficacy Scale-International (FES-I).
        Age Ageing. 2005; 34: 614-619
        • Maricle RA
        • Nutt JG
        • Carter JH
        Mood and anxiety fluctuation in Parkinsons-disease associated with levodopa infusion - preliminary findings.
        Mov Disord. 1995; 10: 329-332
        • Pontone GM
        • Dissanayaka N
        • Apostolova L
        • et al.
        Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease (vol 5, 30, 2019).
        Npj Parkinsons Dis. 2020; 5: 30
        • Joling M
        • van den Heuvel OA
        • Berendse HW
        • et al.
        Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 2018; 89: 89-94
        • Richard IH
        • McDermott MP
        • Kurlan R
        • et al.
        A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
        Neurology. 2012; 78: 1229-1236
        • Menza M
        • Dobkin RD
        • Marin H
        • et al.
        A controlled trial of antidepressants in patients with Parkinson disease and depression.
        Neurology. 2009; 72: 886-892
        • Shiba M
        • Bower JH
        • Maraganore DM
        • et al.
        Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.
        Mov Disord. 2000; 15: 669-677
        • Weisskopf MG
        • Chen HL
        • Schwarzschild MA
        • et al.
        Prospective study of phobic anxiety and risk of Parkinson's disease.
        Mov Disord. 2003; 18: 646-651
        • Arabia G
        • Grossardt BR
        • Geda YE
        • et al.
        Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson's disease.
        Parkinsonism Relat Disord. 2007; 13 (-S): S52
        • Perepezko K
        • Naaz F
        • Wagandt C
        • et al.
        Anxiety in Parkinson's disease: a systematic review of neuroimaging studies.
        J Neuropsychiatry Clin Neurosci. 2021; 33: 280-294
        • Zhang HB
        • Qiu YH
        • Luo YJ
        • et al.
        The relationship of anxious and depressive symptoms in Parkinson's disease with voxel-based neuroanatomical and functional connectivity measures.
        J Affect Disorders. 2019; 245: 580-588
        • Tessitore A
        • Hariri AR
        • Fera F
        • et al.
        Dopamine modulates the response of the human amygdala: a study in Parkinson's disease (vol 22, pg 9099, 2002).
        J Neurosci. 2002; 22 (Cp5-Cp)
        • Vriend C
        • Boedhoe PSW
        • Rutten S
        • et al.
        A smaller amygdala is associated with anxiety in Parkinson's disease: a combined FreeSurfer-VBM study.
        J Neurol Neurosurg Psychiatry. 2016; 87: 493-500
        • Wabnegger A
        • Ille R
        • Schwingenschuh P
        • et al.
        Facial Emotion Recognition in Parkinson's Disease: An fMRI Investigation.
        Plos One. 2015; 10e0136110
        • Heller J
        • Mirzazade S
        • Romanzetti S
        • et al.
        Impact of gender and genetics on emotion processing in Parkinson's disease - a multimodal study.
        Neuroimage Clin. 2018; 18: 305-314
        • Moonen AJH
        • Weiss PH
        • Wiesing M
        • et al.
        An fMRI study into emotional processing in Parkinson's disease: does increased medial prefrontal activation compensate for striatal dysfunction?.
        Plos One. 2017; 12: e0177085
        • Wang XX
        • Li JY
        • Wang M
        • et al.
        Alterations of the amplitude of low-frequency fluctuations in anxiety in Parkinson's disease.
        Neurosci Lett. 2018; 668: 19-23
        • Oosterwijk CS
        • Vriend C
        • Berendse HW
        • et al.
        Anxiety in Parkinson's disease is associated with reduced structural covariance of the striatum.
        J Affect Disorders. 2018; 240: 113-120
        • Carey G
        • Gormezoglu M
        • de Jong JJA
        • et al.
        Neuroimaging of anxiety in Parkinson's Disease: a systematic review.
        Mov Disord. 2021; 36: 327-339
        • Kuring JK
        • Mathias JL
        • Ward L
        Risk of Dementia in persons who have previously experienced clinically-significant Depression, Anxiety, or PTSD: a systematic review and meta-analysis.
        J Affect Disorders. 2020; 274: 247-261
        • Dissanayaka NNW
        • Lawson RA
        • Yarnall AJ
        • et al.
        Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.
        Parkinsonism Relat Disord. 2017; 36: 63-68
        • Forbes EJ
        • Byrne GJ
        • O'Sullivan JD
        • et al.
        Defining atypical anxiety in Parkinson's disease.
        Movement Disorders Clinical Practice. 2021; 8: 571-581
        • Carey G
        • Lopes R
        • Viard R
        • et al.
        Anxiety in Parkinson's disease is associated with changes in the brain fear circuit.
        Parkinsonism Relat Disord. 2020; 80: 89-97
        • Leentjens AFG
        • Dujardin K
        • Pontone GM
        • et al.
        The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.
        Mov Disord. 2014; 29: 1035-1043
        • Dujardin K
        • Moonen AJH
        • Behal H
        • et al.
        Cognitive disorders in Parkinson's disease: confirmation of a spectrum of severity.
        Parkinsonism Relat Disord. 2015; 21: 1299-1305
        • Fanciulli A
        • Assogna F
        • Caltagirone C
        • et al.
        Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia.
        Aging Clin Exp Res. 2013; 25: 601-603
        • Ghielen I
        • van Wegen EEH
        • Rutten S
        • et al.
        Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial.
        J Psychosom Res. 2017; 103: 1-8
        • Pontone GM
        • Mills KA
        Optimal Treatment of Depression and Anxiety in Parkinson's Disease.
        Am J Geriatr Psychiatry. 2021; 29: 530-540
        • Weintraub D
        • Aarsland D
        • Chaudhuri KR
        • et al.
        The neuropsychiatry of Parkinson's disease: advances and challenges.
        Lancet Neurol. 2022; 21: 89-102
        • Fleminger S
        Left-sided Parkinson's disease is associated with greater anxiety and depression.
        Psychol Med. 1991; 21: 629-638
        • Lauterbach EC
        • Freeman A
        • Vogel RL
        Differential DSM-111 psychiatric disorder prevalence profiles in dystonia and Parkinson's disease.
        J Neuropsychiatry Clin Neurosci. 2004; 16: 29-36
        • Leentjens AFG
        • Dujardin K
        • Marsh L
        • et al.
        Anxiety rating scales in parkinson's disease: a validation study of the hamilton anxiety rating scale, the beck anxiety inventory, and the hospital anxiety and depression scale.
        Mov Disord. 2011; 26: 407-415
        • Menza MA
        • Robertson-Hoffman DE
        • Bonapace AS
        Parkinson's disease and anxiety: comorbidity with depression.
        Biol Psychiatry. 1993; 34: 465-470
        • Qureshi SU
        • Amspoker AB
        • Calleo JS
        • et al.
        Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression.
        J Geriatr Psychiatry Neurol. 2012; 25: 233-239
        • Stein MB
        • Heuser IJ
        • Juncos JL
        • et al.
        Anxiety disorders in patients with Parkinson's disease.
        Am J Psychiatry. 1990; 147: 217-220
        • Tudorica V
        • Zaharia C
        • Pirscoveanu D
        • et al.
        Study on anxiety in patients with Parkinson's disease.
        Rom J Neurol. 2009; 7: 46-49
        • American Psychiatric Association
        Diagnostic and Statisticial Manual of Mental Disorders.
        4th ed. (DSM-IV). American Psychiatric Association, Washington, D.C1994
        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders.
        3rd rev. ed. (DSM-III-R). American Psychiatric Association, Washington, D.C1987
        • American Medical Association
        International Classification of Diseases.
        9th revision. American Medical Association, Chicago, Ill1999 (Clinical modification: ICD-9-CM)
        • Wing JK
        • Cooper JE
        • Sartorius N
        Measurement and classification of psychiatric symptoms; An instruction manual for the PSE and Catego program.
        Cambridge University Press, London1974
        • Sheehan DV
        • Lecrubier Y
        • Sheehan KH
        • et al.
        The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
        J Clin Psychiatry. 1998; 59 (quiz 4-57): 22-33
        • Zung WW
        A rating instrument for anxiety disorders.
        Psychosomatics. 1971; 12: 371-379
        • Robins LN
        • Helzer JE
        • Croughan J
        • et al.
        "National-institute-of-mental-health diagnostic interview schedule - its history, characteristics, and validity.
        Arch Gen Psychiat. 1981; 38: 381-389
        • Mannuzza S
        • Fyer AJ
        • Klein DF
        • et al.
        Schedule for affective-disorders and schizophrenia - lifetime version modified for the study of anxiety disorders (Sads-La) - rationale and conceptual development.
        J Psychiatr Res. 1986; 20: 317-325
        • Goetz CG
        • Tilley BC
        • Shaftman SR
        • et al.
        Movement disorder society-sponsored revision of the unified parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results.
        Mov Disord. 2008; 23: 2129-2170
        • Folstein MF
        • Robins LN
        • Helzer JE
        The mini-mental state examination.
        Arch Gen Psychiat. 1983; 40: 812
        • Mayeux R
        • Stern Y
        • Rosen J
        • et al.
        Depression, intellectual impairment, and Parkinson disease.
        Neurology. 1981; 31: 645-650
        • Jenkinson C
        • Fitzpatrick R
        • Peto V
        • et al.
        The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire.
        Psychol Health. 1997; 12: 805-814
        • Teng EL
        • Chui HC
        The modified mini-mental state (3ms) examination.
        J Clin Psychiatry. 1987; 48: 314-318
        • Melo LM
        • Chien HF
        • Barbosa ER
        Identification of wearing-off manifestations (reduction of levodopa effect) in Parkinson's disease using specific questionnaire and comparison of the results with routine ambulatory evaluations.
        Arq Neuro-Psiquiat. 2010; 68: 506-510
        • Raudino F
        Non motor off in Parkinson's disease.
        Acta Neurol Scand. 2001; 104: 312-315
        • Copeland JR
        • Kelleher MJ
        • Kellett JM
        • et al.
        A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability.
        Psychol Med. 1976; 6: 439-449
        • Bech P
        • A C
        The Hamilton scales.
        1st ed. Springer, Berlin, Heidelberg1990
        • Beck AT
        • Steer RA
        Beck Anxiety Inventory Manual.
        Psychological Corporation, San Antonio, TX1993
        • Mccormack HM
        • Horne DJD
        • Sheather S
        Clinical-applications of visual analog scales - a critical-review.
        Psychol Med. 1988; 18: 1007-1019
        • Zigmond AS
        • Snaith RP
        The hospital anxiety and depression scale.
        Acta Psychiat Scand. 1983; 67: 361-370
        • Spielberger CD
        • Gorsuch RL
        • Lushene R
        • et al.
        Manual for the State-Trait Anxiety Inventory.
        Consulting Psychologists Press, Palo Alto, CA1983
        • Snaith RP
        • Baugh SJ
        • Clayden AD
        • et al.
        The Clinical Anxiety Scale - an Instrument Derived from the Hamilton Anxiety Scale.
        Br J Psychiatry. 1982; 141: 518-523
        • Chaudhuri KR
        • Healy DG
        • Schapira AH
        • et al.
        Non-motor symptoms of Parkinson's disease: diagnosis and management.
        Lancet Neurol. 2006; 5: 235-245
        • Jonasson SB
        • Ullen S
        • Iwarsson S
        • et al.
        Concerns about falling in Parkinson's disease: associations with disabilities and personal and environmental factors.
        J Parkinson Dis. 2015; 5: 341-349
        • Jonasson SB
        • Nilsson MH
        • Lexell J
        • et al.
        Experiences of fear of falling in persons with Parkinson's disease - a qualitative study.
        Bmc Geriatr. 2018; 18: 44
        • Mak MKY
        • Pang MYC
        • Mok V
        Gait difficulty, postural instability, and muscle weakness are associated with fear of falling in people with parkinson's disease.
        Parkinsons Dis. 2012; 2012: 901721
        • Tinetti ME
        • Richman D
        • Powell L
        Falls efficacy as a measure of fear of falling.
        J Gerontol. 1990; 45: P239-PP43
        • Powell LE
        • Myers AM
        The activities-specific balance confidence (Abc) scale.
        J Gerontol A Biol Sci Med Sci. 1995; 50: M28-M34
        • Yardley L
        • Smith H
        A prospective study of the relationship between feared consequences of falling and avoidance of activity in community-living older people.
        Gerontologist. 2002; 42: 17-23
        • Tinetti ME
        Performance-oriented assessment of mobility problems in elderly patients.
        J Am Geriatr Soc. 1986; 34: 119-126
        • Velozo CA
        • Peterson EW
        Developing meaningful fear of falling measures for community dwelling elderly.
        Am J Phys Med Rehab. 2001; 80: 662-673
        • McRae C
        • Diem G
        • Vo A
        • et al.
        Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings.
        Parkinsonism Relat Disord. 2002; 8: 187-192
        • Oehlert ME
        • Hass SD
        • Freeman MR
        • et al.
        The neurobehavioral cognitive status examination: accuracy of the ''screen-metric'' approach in a clinical sample.
        J Clin Psychol. 1997; 53: 733-737